Bone Marrow Transplantation Clinical Trial
Official title:
Massage for Children Undergoing Bone Marrow Transplantation
Undergoing bone marrow transplantation (BMT) is associated with a high level of distress for
patients and caregivers. Clinical research studies have reported benefits from massage for
a) oncology patients, b) children, c) adults and children undergoing bone marrow
transplants. A multi-center study of an intervention using a combination of massage therapy
and a laugh cart to reduce distress in pediatric oncology patients undergoing BMT (PI:
Phipps) is completed with results not yet published. There is still a need for independent
studies to isolate the effect of massage for clinical outcomes (such as improved nausea and
pain control) in children. Furthermore, this study will test the acceptability of an
augmented massage intervention. In addition to provider-child massage, the augmented massage
intervention includes training of the resident parent to provide additional parent-child
massage, to relieve symptoms as needed. The goal of this augmented intervention is the
improvement of symptom management in patients and decreased stress and feelings of
helplessness in parents.
We propose a randomized pilot study at the UCSF pediatric bone marrow transplant center to
assess the feasibility of a higher-quality study of the effects of massage in this
population.
Aim 1: Determine the acceptability of a massage intervention for patients and parents on a
pediatric bone marrow transplant unit.
Aim 2: Explore the logistics of implementing the augmented massage intervention at the
bedside offered to consecutive patients over one year's time.
Aim 3: Collect preliminary data for patients and parents including patient clinical
outcomes, quality of life, and satisfaction, and parental stress and mood to allow sample
size calculations for further studies.
Status | Completed |
Enrollment | 23 |
Est. completion date | January 2010 |
Est. primary completion date | January 2010 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 5 Years to 18 Years |
Eligibility |
Inclusion Criteria: - Being 5 to 18 years old - Admitted for BMT. Rationale: This is a pediatric study for children up to age 18 admitted to the BMT unit. Questionnaires are not designed for children under age 5. Exclusion Criteria: - Parent or child unable to answer questionnaire due to language limitations. Rationale: The pilot character of the study with its limited budget does not include instruments in foreign languages, such as Chinese or Spanish. This could be a project for further studies. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Country | Name | City | State |
---|---|---|---|
United States | Childrens' Hospital UCSF | San Francisco | California |
Lead Sponsor | Collaborator |
---|---|
University of California, San Francisco |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of Days With Pain Scores >3 Measured on Numeric Rating Scale (Range 0-10; 0 for no Pain; 10 for Worst Pain Imaginable) | days of pain >3 by nurses notes based on pain scores on numeric rating scale (up to 28 days) | 7 days pre to 21 days post transplant = 28 days | No |
Secondary | Number of Vomiting Episodes | number of vomiting episodes as reported by nurses per occurence (no upper limit) | day -7 to +21 around transplant date | No |
Secondary | Days of Hospital Stay | days of hospital stay after bone marrow transplant (up to 100 days; participant observation was censored after 100 days) | days of hospital stay after bone marrow transplant | No |
Secondary | Days to Recovery Neutrophil Count | number of days to recovery neutrophil count >500 cells per microliter for 2 consecutive days (range, up to 100 days, censored at 100 days) | hospital stay | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06148610 -
Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support
|
||
Completed |
NCT02212236 -
Psychological Intervention for Distress During HSCT
|
Phase 2 | |
Completed |
NCT00023530 -
Blood and Marrow Transplant Clinical Research Network
|
N/A | |
Completed |
NCT01466335 -
An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers
|
Phase 1 | |
Withdrawn |
NCT02682953 -
Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers
|
Phase 2 | |
Completed |
NCT00775632 -
Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants
|
Phase 2 | |
Completed |
NCT00048256 -
Relationship Between Personality and Coping Styles in Bone Marrow Transplant Candidates
|
N/A | |
Completed |
NCT00004994 -
Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive Chemotherapy and Radiation Preceding a Bone Marrow Transplant
|
N/A | |
Completed |
NCT04039100 -
Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease
|
N/A | |
Completed |
NCT04535570 -
Evolution of the Energy Expenditure During Hematopoietic Stem Cell Transplantation
|
||
Recruiting |
NCT06118853 -
Impact of Yoga and Gentle Massage Practices on Symptom Management in Patients Undergoing HSCT
|
N/A | |
Active, not recruiting |
NCT01016093 -
Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major Patients
|
Phase 2/Phase 3 | |
Completed |
NCT01015183 -
Prevention Chemotherapy Induced Mucositis by Zinc Sulfate
|
Phase 2/Phase 3 | |
Completed |
NCT00000591 -
T-Cell Depletion in Unrelated Donor Marrow Transplantation
|
Phase 3 | |
Completed |
NCT04474730 -
Physical Activity Monitoring Among BMT Patients
|
N/A | |
Completed |
NCT02733744 -
Fecal Microbiota Transplantation After HSCT
|
Early Phase 1 | |
Active, not recruiting |
NCT02319226 -
Toward Immune Biomarkers for Tolerance and GvHD in Humans
|
||
Recruiting |
NCT00673348 -
Therapeutic Drug Monitoring (TDM) of Voriconazole and Correlation With CYP2C19 Genotype in Korean Populations
|
N/A | |
Completed |
NCT00005556 -
Retention of Bone Marrow Donors in a National Registry
|
N/A | |
Completed |
NCT05391347 -
Effects of Orange Oil Aromatherapy on the Pain and Anxiety
|
N/A |